Table 4.

Prevalence of HPV genotypes covered by the bi-, quadri-, and nonavalent vaccine among participants with a CIN2± diagnosis, by race/ethnicity.

	N=163 (%)	Non-Hispanic White N=118	Non-Hispanic Black N=13	Hispanic N=30	Asian N=21	Fisher’s exact test P-value
						0.117
Bi-/Quadrivalent coverage	62 (38.0%)	15.0%	16.7%	17.9%	18.8%
Nonavalent coverage	75 (46.0%)	45.8%	8.3%	25.0%	31.3%
Not covered by any vaccine	26 (16.0%)	39.3%	75.0%	57.1%	50.0%

^bParticipants were considered ‘not covered’ if no types in their sample were included in any vaccine.